NDC 0069-0400-01 - Zithromax
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0069-0400
- Requested NDC
- 0069-0400-01
- Package NDCs from labels
- 0069-0400-01, 0069-0400-10
- Manufacturer
- Pfizer Laboratories Div Pfizer Inc | Pharmacia & Upjohn Company LLC | Pfizer Ireland Pharmaceuticals Unlimited Company
- Effective date
- 2026-09-09
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Zithromax | Pfizer Laboratories Div Pfizer Inc | Pharmacia & Upjohn Company LLC | Pfizer Ireland Pharmaceuticals Unlimited Company | 2026-09-09 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0069-0400-01 | Zithromax | 5 mL in 1 VIAL | INJECTION, POWDER, LYOPHILIZED, | 5 | 25 | |
| 0069-0400-10 | Zithromax | 10 in 1 CARTON | INJECTION, POWDER, LYOPHILIZED, | 10 | 25 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 0069-0400 | ZITHROMAX (AZITHROMYCIN DIHYDRATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [PFIZER LABORATORIES DIV PFIZER INC] | 25 | Current NDC, Legacy NDC, 2 package rows | 20250212_8d24bacb-feff-4c6a-b8df-625e1435387a.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0069-0400-01 | EA - Each | 0069-0400 | d7c08308-f15a-4aba-9d7c-7c2716a206c1 | 1 | 2014-04-03 |
| 0069-0400-10 | EA - Each | 0069-0400 | e0653e4e-6e09-4e11-a661-10801d9d44eb | 1 | 2014-04-03 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| AZITHROMYCIN DIHYDRATE | ACTIVE INGREDIENT | 5FD1131I7S | ZITHROMAX (AZITHROMYCIN DIHYDRATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [PFIZER LABORATORIES DIV PFIZER INC] | 7 | |
| AZITHROMYCIN ANHYDROUS | ACTIVE MOIETY | J2KLZ20U1M | ZITHROMAX (AZITHROMYCIN DIHYDRATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [PFIZER LABORATORIES DIV PFIZER INC] | 7 | |
| CITRIC ACID MONOHYDRATE | INACTIVE INGREDIENT | 2968PHW8QP | ZITHROMAX (AZITHROMYCIN DIHYDRATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [PFIZER LABORATORIES DIV PFIZER INC] | 7 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | ZITHROMAX (AZITHROMYCIN DIHYDRATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [PFIZER LABORATORIES DIV PFIZER INC] | 7 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Azithromycin | AZITHROMYCIN | Bryant Ranch Prepack | b5d79719-b1dc-469f-a19c-f8ba615138f0 | 2026-05-14 | Warnings, Adverse reactions | 5FD1131I7S |
| Market Basket Effervescent Antacid and Pain Relief | ASPIRIN, CITRIC ACID, SODIUM BICARBONATE | Demoulas Super Markets, Inc. | e15439c7-0e3c-7752-e053-2995a90a1a40 | 2026-05-11 | Warnings | XF417D3PSL |
| Meijer Effervescent Antacid and Pain Relief | ASPIRIN, ANHYDROUS CITRIC ACID, SODIUM BICARBONATE | Meijer Distribution Inc | 7305972b-aa0f-4daa-e053-2991aa0adfd7 | 2026-05-11 | Warnings | XF417D3PSL |
| azithromycin | AZITHROMYCIN | Coupler LLC | 510024c9-6658-e08f-e063-6294a90a0793 | 2026-05-04 | Warnings, Adverse reactions | 5FD1131I7S |
| CLENPIQ | SODIUM PICOSULFATE, MAGNESIUM OXIDE, AND ANHYDROUS CITRIC ACID | Ferring Pharmaceuticals Inc. | e95fff66-4ec0-4001-a727-33e66a5ec7d5 | 2026-04-15 | Warnings, Adverse reactions | XF417D3PSL |
| Azithromycin Dihydrate | AZITHROMYCIN DIHYDRATE | Precision Dose, Inc. | d9b66736-3f1a-4d6d-bdc4-274f5adfb40c | 2026-04-14 | Warnings, Adverse reactions | 5FD1131I7S |
| azithromycin | AZITHROMYCIN | Cardinal Health 107, LLC | ea128124-8712-4998-be46-47d43ef127d4 | 2026-04-10 | Warnings, Adverse reactions | 5FD1131I7S |
| Azithromycin Dihydrate | AZITHROMYCIN DIHYDRATE | Precision Dose, Inc. | 3962bc34-8236-4ac1-8ffd-2edbd430c3eb | 2026-04-08 | Warnings, Adverse reactions | 5FD1131I7S |
| Azithromycin | AZITHROMYCIN | Bryant Ranch Prepack | a81212ef-76b6-4bd7-8706-3d2b05ee34f9 | 2026-03-30 | Warnings, Adverse reactions | 5FD1131I7S |
| Azithromycin | AZITHROMYCIN | A-S Medication Solutions | 24c07398-84ad-48e2-9625-e9073c28fb73 | 2026-03-24 | Warnings, Adverse reactions | 5FD1131I7S |
| Azithromycin | AZITHROMYCIN | A-S Medication Solutions | 77c5e4c6-6d16-40fe-bf36-cb441348f39b | 2026-03-24 | Warnings, Adverse reactions | 5FD1131I7S |
| Azithromycin | AZITHROMYCIN | AvKARE | dc633b7d-5154-7e43-e053-2a95a90ad2a6 | 2026-03-17 | Warnings, Adverse reactions | 5FD1131I7S |
| AZITHROMYCIN DIHYDRATE | AZITHROMYCIN DIHYDRATE | DIRECT RX | a6426d5f-5518-3c69-e053-2995a90af50f | 2026-03-17 | Warnings, Adverse reactions | 5FD1131I7S |
| AZITHROMYCIN | AZITHROMYCIN | DIRECT RX | a5b4092d-ab72-f5d1-e053-2995a90ac582 | 2026-03-17 | Warnings, Adverse reactions | 5FD1131I7S |
| Azithromycin | AZITHROMYCIN | Preferred Pharmaceuticals Inc. | 003307c5-3f73-4a5d-a704-bfdea3c656e8 | 2026-03-16 | Warnings, Adverse reactions | 5FD1131I7S |
| Azithromycin | AZITHROMYCIN | Preferred Pharmaceuticals Inc. | 4eec460d-5ba8-4614-8700-219a9b4fc385 | 2026-03-16 | Warnings, Adverse reactions | 5FD1131I7S |
| Azithromycin | AZITHROMYCIN | Preferred Pharmaceuticals Inc. | a1c96531-bbd2-4dc5-8eeb-3f0276cd0956 | 2026-03-11 | Warnings, Adverse reactions | 5FD1131I7S |
| Azithromycin Dihydrate | AZITHROMYCIN DIHYDRATE | A-S Medication Solutions | de5b0c2b-9a7d-46e9-8169-4100442efa9b | 2026-03-03 | Warnings, Adverse reactions | 5FD1131I7S |
| azithromycin | AZITHROMYCIN | Rising Pharma Holdings, Inc. | 5199689f-8881-7757-e063-6394a90ae2eb | 2026-02-26 | Warnings, Adverse reactions | 5FD1131I7S |
| Kidnex IV | GINKGO BILOBA, ALPHA-KETOGLUTARICUM ACIDUM, CITRICUM ACIDUM, FUMARICUM ACIDUM, MALICUM ACIDUM, PYRUVIC ACID, SUCCINICUM ACIDUM, ARGENTUM METALLICUM, AURUM METALLICUM, CUPRUM METALLICUM, GERMANIUM SESQUIOXIDE, MERCURIUS VIVUS, NUX VOMICA, KIDNEY (SUIS), LYMPH NODE (SUIS), NAPHTHOCHINONUM, NATRUM OXALACETICUM, PHOSPHORUS, URINARY BLADDER (SUIS), ACONITICUM ACIDUM, CIS- | Energique, Inc. | 23de6b8e-7622-4ba6-89f7-37bd151687e2 | 2026-02-26 | Warnings | XF417D3PSL |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.